Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,310,361
in 7 filings, $252K under 10b5-1 plans

Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-11-06 Szela Mary T Director Grant or award · Option to purchase common stock +7,583 7,583
2018-08-21 GRASSO MARC CFO, CBO Grant or award · Option to purchase common stock +250,000 250,000
2018-07-02 FARNAM JOHN Chief Operating Officer Grant or award · Option to purchase common stock +115,000 115,000
2018-06-07 Stein Steven H Director Grant or award · Option to purchase common stock +13,000 13,000
2018-06-07 Malley Thomas Director Grant or award · Option to purchase common stock +13,000 13,000
2018-06-07 Hasnain Faheem Director Grant or award · Option to purchase common stock +13,000 13,000

Page 19 of 19 · 366 trades